Owen's Fight 4 Life


                
               FAITH -- FAMILY-- FRIENDS -- FUTURE
Alternative Treatments
OCCAM - The Office of Cancer Complementary and Alternative Medicine (OCCAM) was established in October 1998 to coordinate and enhance the activities of the National Cancer Institute (NCI) in the arena of complementary and alternative medicine (CAM).

http://www.cancer.gov/cam/


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

 


Dr. Nicholas Gonzalez:
New York, NY

Dr. Gonzalez' website:  http://www.dr-gonzalez.com/regimen.htm

The Morning Show With Mike and Juliet, Fox Network, Sept. 21, 2007:  http://www.mandjshow.com/videos/cancer-survival-tips/
     Interview with Kris Carr and Dr. Gonzalez; or click on "Videos": "Real Life Stories"

Alternative Medicine magazine, April 2002:  http://members.aol.com/pbchowka/gonzalez2002.html

Alternative Therapies magazine, Jan/Feb 2007: http://www.alternative-therapies.com/at/web_pdfs/gonzalez.pdf

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Dr. Burton Berkson:
Las Cruces, NM


Abstract article from Integrative Cancer Therapies Journal; Sept., 2006: "The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous {alpha}-Lipoic Acid/Low-Dose Naltrexone Protocol"  
http://ict.sagepub.com/cgi/content/abstract/5/1/83ict.sagepub.com/cgi/content/abstract/5/1/83



About Dr. Berkson: http://www.cancercontrolsociety.com/bios-old/Berkson.htm
 
http://www.cancercontrolsociety.com/bios-old/Berkson.htm

May, 2007: NCI Hosts Conference on LDN and Related Substances.  On the afternoon of April 20th, at its offices in Rockville, Maryland, the National Cancer Institute (part of the US government's National Institutes of Health, or NIH) held a conference entitled “Low Dose Opioid Blockers, Endorphins, and Metenkephalin: Promising Compounds for Unmet Medical Needs.” LDN’s Effectiveness Highlighted in New Presentations.

  We have received permission to display the following two complete slide presentations, which portray the important therapeutic effects of LDN in a broad array of challenging human illnesses:
  • Dr. Burton Berkson, MD, PhD, a clinician from Las Cruces, New Mexico, contributed a copy of his presentation from the April 2007 meeting hosted by the National Cancer Institute (see above). The slides include multiple images of CT scans and PET scans that document unprecedented remissions in heretofore terminally ill patients.




GoDaddy.com